Alerts will be sent to your verified email
Verify EmailGODAVARI
|
Godavari Drugs
|
Asston Pharma
|
Onyx Biotec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.06 % | 31.69 % | 13.47 % |
|
5yr average Equity Multiplier
|
3.51 | 5.73 | 2.51 |
|
5yr Average Asset Turnover Ratio
|
1.24 | 0.79 | 0.82 |
|
5yr Avg Net Profit Margin
|
3.28 % | 10.83 % | 6.72 % |
|
Price to Book
|
1.48 | 6.34 | 1.2 |
|
P/E
|
18.04 | 15.75 | 13.54 |
|
5yr Avg Cash Conversion Cycle
|
107.21 Days | 121.8 Days | 36.81 Days |
|
Inventory Days
|
47.15 Days | 31.3 Days | 48.71 Days |
|
Days Receivable
|
163.82 Days | 296.65 Days | 104.89 Days |
|
Days Payable
|
106.32 Days | 343.23 Days | 101.26 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | 3.57 | 4.89 |
|
5yr Avg ROCE
|
20.07 % | 42.37 % | 12.63 % |
|
5yr Avg Operating Profit Margin
|
8.03 % | 15.11 % | 14.14 % |
|
5 yr average Debt to Equity
|
1.34 | 1.99 | 0.95 |
|
5yr CAGR Net Profit
|
1.18 % | 108.46 % | 8.12 % |
|
5yr Average Return on Assets
|
4.0 % | 7.75 % | 5.64 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.61 % | 50.66 % | 65.1 % |
|
Share Pledged by Promoters
|
0.22 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.51 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Godavari Drugs
|
Asston Pharma
|
Onyx Biotec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|